SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-15-000009
Filing Date
2015-01-08
Accepted
2015-01-08 17:01:17
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 OXIS INTERNATIONAL QUARTERLY REPORT oxis10q033114.htm 10-Q 496939
2 CERTIFICATION SECTION 302 ex311.htm EX-31.1 13985
3 CERTIFICATION SECTION 302 ex312.htm EX-31.2 12414
4 CERTIFICATION SECTION 906 ex321.htm EX-32.1 5942
5 CERTIFICATION SECTION 906 ex322.htm EX-32.2 5990
  Complete submission text file 0001513160-15-000009.txt   2684844

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxis-20140331.xml EX-101.INS 311677
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20140331.xsd EX-101.SCH 20137
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oxis-20140331_cal.xml EX-101.CAL 38113
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20140331_def.xml EX-101.DEF 43522
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20140331_lab.xml EX-101.LAB 163310
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20140331_pre.xml EX-101.PRE 120323
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 15516970
SIC: 2834 Pharmaceutical Preparations